Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 32
Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.
Metrics to compare | 014570 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship014570PeersSector | |
---|---|---|---|---|
P/E Ratio | −135.4x | 3.1x | −0.6x | |
PEG Ratio | 1.22 | 0.03 | 0.00 | |
Price/Book | 0.7x | 0.7x | 2.6x | |
Price / LTM Sales | 0.7x | 0.7x | 3.1x | |
Upside (Analyst Target) | - | 37.4% | 48.7% | |
Fair Value Upside | Unlock | 11.1% | 7.7% | Unlock |